Prenetics Global Limited (PRENW)
0.01
-0.00 (-20.63%)
At close: Mar 12, 2025, 1:38 PM
-20.63% (1D)
| Bid | 0.01 |
| Market Cap | 43.84M |
| Revenue (ttm) | 8.57B |
| Net Income (ttm) | -16.42B |
| EPS (ttm) | -11.041 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.01 |
| Volume | 201 |
| Avg. Volume (20D) | 79,744.408 |
| Open | 0.01 |
| Previous Close | 0.01 |
| Day's Range | 0.01 - 0.01 |
| 52-Week Range | 0.01 - 0.01 |
| Beta | -0.31 |
About PRENW
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date n/a
Employees 320
Stock Exchange NASDAQ
Ticker Symbol PRENW
Website https://www.prenetics.com